Compounds > n-benzyl-n-hydroxy-5-phenylpentamide
Page last updated: 2024-09-04

n-benzyl-n-hydroxy-5-phenylpentamide and Diabetic Glomerulosclerosis

n-benzyl-n-hydroxy-5-phenylpentamide has been researched along with Diabetic Glomerulosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adler, SG; Becerra, D; Clemmons, B; Kim, N; Lanting, L; LaPage, J; Ma, J; Mandal, M; Nast, CC; Natarajan, R; Surya Prakash, GK1

Other Studies

1 other study(ies) available for n-benzyl-n-hydroxy-5-phenylpentamide and Diabetic Glomerulosclerosis

ArticleYear
12/15-lipoxygenase inhibitors in diabetic nephropathy in the rat.
    Prostaglandins, leukotrienes, and essential fatty acids, 2005, Volume: 72, Issue:1

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Albuminuria; Amides; Animals; Benzylamines; Caffeic Acids; Collagen Type IV; Creatinine; Diabetic Nephropathies; Kidney Glomerulus; Lipoxygenase Inhibitors; Male; Rats; Rats, Sprague-Dawley

2005